Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03759262 · ClinicalTrials.gov registry record · Phase 1
Ultra-high Dose Vitamin D for HSCT
A Phase 1 study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT03759262 is a Phase 1 study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 33 participants.
The verdict
NCT03759262, a Phase 1 study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
This is a pilot study to investigate the effects of achieving adequate vitamin D levels via ultra-high-dose vitamin D supplementation given prior to hematopoietic stem cell transplant on transplant-related complications and inflammatory biomarkers.
Interventions
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-12-10 |
| Est. Completion | 2020-05-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03759262
The ClinicalTrials.gov registry entry for NCT03759262 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholecalciferol is the first listed.
NCT03759262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03759262 about?
NCT03759262 is a clinical study titled "Ultra-high Dose Vitamin D for HSCT". This is a pilot study to investigate the effects of achieving adequate vitamin D levels via ultra-high-dose vitamin D supplementation given prior to hematopoietic stem cell transplant on transplant-related complications and inflammatory biomarkers.
What is the current status of trial NCT03759262?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2018-12-10. Estimated completion is 2020-05-10.
What interventions are being tested in trial NCT03759262?
The interventions under investigation include: Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT03759262?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.